Skip to Content

Ablavar

Previous name: Vasovist
Active Substance: gadofosveset trisodium
Common Name: gadofosveset trisodium
ATC Code: V08CA
Marketing Authorisation Holder: TMC Pharma Services Ltd.
Active Substance: gadofosveset trisodium
Status: Withdrawn
Authorisation Date: 2005-10-03
Therapeutic Area: Magnetic Resonance Angiography
Pharmacotherapeutic Group: Contrast media

Therapeutic Indication

This medicinal product is for diagnostic use only.

AblavarĀ is indicated for contrast-enhanced magnetic resonance angiography (CE-MRA) for visualisation of abdominal or limb vessels in adults only, with suspected or known vascular disease.

The marketing authorisation for Ablavar has been withdrawn at the request of the marketing authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide